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Background: There is evidence that one of the key type 2 diabetes (T2D) loci identified by GWAS exerts its
influence early on in life through its impact on pediatric BMI. This locus on 10q23 harbors three genes,
encoding hematopoietically expressed homeobox (HHEX), insulin-degrading enzyme (IDE) and kinesin family
member 11 (KIF11), respectively.
Methods: We analyzed the impact of adipogeneis on the mRNA and protein expression levels of these genes in
the human adipocyte Simpson-Golabi-Behmel syndrome (SGBS) cell line in order to investigate which could be
the culprit gene(s) in this region of linkage disequilibrium.
Results: Following activation of differentiation with a PPARγ ligand, we observed ~20% decrease in IDE, ~40%
decrease in HHEX and in excess of 80% decrease in KIF11 mRNA levels when comparing the adipocyte and
pre-adipocyte states. We also observed decreases in KIF11 and IDE protein levels, but conversely we observed a
dramatic increase in HHEX protein levels. Subsequent time course experiments revealed some marked changes
in expression as early as three hours after activation of differentiation.
Conclusion: Our data suggest that the expression of all three genes at this locus are impacted during SGBS
adipogenesis and provides insights in to the possible mechanisms of how the genes at this 10q23 locus could
influence both adipocyte differentiation and susceptibility to T2D through insulin resistance.
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Genome wide association studies (GWAS) have revealed
robust signals for both body mass index (BMI) and type
2 diabetes (T2D) [1-5]. In the case of the strongest asso-
ciated loci with BMI and T2D to date, namely FTO [6]
and TCF7L2 [7] respectively, they are the only genes
harbored in their respective regions of linkage disequi-
librium where the GWAS signal resides, making them
obvious candidates for the culprit gene at these given
locations. However this is not always the case for the
other GWAS loci reported, most notably the multi-
gene 10q23 T2D locus [1].* Correspondence: grants@chop.edu
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reproduction in any medium, provided the orWe previously investigated in a pediatric setting all the
main loci identified by T2D GWAS and reported that
only the 10q23 variant allele was also associated with
increased BMI in childhood, suggesting that it exerts its
influence early on in life [8]. In addition, this locus has
also been reported to be associated with BMI in children
at eight years of age who were born large for gestational
age to a parent with type 1 diabetes [9].
The 10q23 locus contains three genes within the
region of linkage disequilibrium harboring the T2D
and BMI associated signal, encoding insulin-degrading
enzyme (IDE), kinesin family member 11 (KIF11) and
hematopoietically expressed homeobox (HHEX), respect-
ively down the chromosomal arm, with KIF11 and
HHEX transcribed on the sense strand. Based on the
observations that this locus impacts BMI early in life,
we hypothesized that the culprit gene(s) at this locustd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to use the Simpson-Golabi-Behmel syndrome (SGBS)
cell line, commonly used to study human adipocyte biol-
ogy [10-13], to investigate the expression of these three
genes at the mRNA and protein level during cell adipo-
genesis. This in turn allowed us to test our hypothesis
and to investigate if we could determine which gene(s)
in this region was the culprit with respect to the previ-
ously reported association with T2D and pediatric BMI.
Methods
Cell culture
SGBS cells were obtained from Dr. Martin Wabitsch’s
lab at the University of Ulm [12]. Culturing the pre-
adipocyte state of the SGBS cells and the subsequent dif-
ferentiation of the cells to adipocytes was carried out
as previously described [12]. Cells were considered pre-
adipocytes before the addition of the differentiation
medium and were subsequently considered adipocytes
once lipidation was observed. The percentage of differ-
entiation was 90%, as determined by counting the num-
ber of cells containing lipid droplet versus the cells
without lipid droplet. Either Troglitazone (Sigma Inc) or
Rosiglitazone (Cayman Chemicals) was used as the
PPARγ ligand in the culture medium (0.008 mg/ml bio-
tin, 0.004 mg/ml panthanoate, 1% penicillin/strepto-
mycin, 10 mg/L transferrin, 1uM insulin, 0.2nM T3,
250nM Dexamethasone, 500uM IBMX and 2uM Rosigli-
tazone or Troglitazone). Cell images were captured
using a Zeiss confocal microscope.
Quantitative polymerase chain reaction
RNA was purified with the RNAeasy kit (Qiagen Inc)
and then the cDNA was synthesized using the Advantage
RT-for-PCR kit (Clontech laboratories). Fully quantitative
PCR was carried out using Power SYBR green qPCR
mastermix (Applied Biosystems Inc) on the 7900HT
real-time PCR system (Applied Biosystems Inc). All pri-
mers (Additional file 1: Table S1) had a single peak in
the dissociation curve following PCR. The Day 0 value
was arbitrarily set at 1. At least three independent
experiments were performed, of which the mean +/−S.D.
is presented.
Western blot
Whole cell protein was extracted in RIPA (Radio-immu-
noprecipitation Assay) buffer (150 mM NaCl, 1% IGE-
PAL CA-630, 0.5% sodium deoxycholate, 0.1%SDS,
50 mM Tris–HCl, pH8.0). Protein concentrations were
measured by BCA protein assay kit (Thermo Scientific)
as described previously [14]. Proteins were separated in
a Nupage 10% BT gel (Invitrogen Inc) and transferred to a
polyvinylidene difluoride (PVDF) membrane (Amersham).
The chemiluminescent reagent, ECL plus (Amersham),was used for detection. The primary antibodies used in
this study were for HHEX (ab79392, Abcam), KIF11
(Abcam), IDE (Thermo Scientific), RAN (BD bios-
ciences) and 36B4 (Abcam). At least three independent
experiments were performed, with representative figures
presented.
Loading controls
Loading controls used commonly, such as GAPDH and
actin, change greatly during the adipogenesis process
perhaps reflecting structural changes in the cell during
adipogenesis. RAN was used as a loading control by
Schupp M et al. [15]. Similar to RAN, 36B4 is a nuclear
protein. In our experience, both RAN and 36B4 decrease
slightly during adipogenesis, the level of change is trivial
comparing to the change we observed with HHEX and
KIF11. Thus we used RAN and 36B4 interchangeably
as loading controls in these experiments to illustrate the
change in HHEX and KIF11 protein expression levels.
PPARG agonists
Both rosiglitazone and troglitazone are PPARG agonists
so the fact that we observed similar results using both
ligands further supports our results. Rosiglitazone is
typically a more potent ligand than troglitazone, and it
takes a shorter time for lipids to form. Rosiglitazone and
troglitazone are often used interchangeably [16].
Results
Comparison of mRNA and protein expression levels
between the pre-adipocyte and adipocyte stages of
SGBS cells
The SGBS cells were cultured in differentiation medium
supplemented with troglitazone for 27–49 days. After
49 days, accumulation of lipid droplets was observed
indicating a mature adipocyte state (Figure 1A). The
mRNA and protein isolations were carried out in parallel
but in separate culture dishes.
For the mRNA expression analyses, PPARγ and RARγ
were used as positive controls [17]. The housekeeping
gene, 36B4, was used as a normalization control. There
was indeed a marked increase (>50 fold) of PPARγ
mRNA in adipocytes compared to the pre-adipocyte
state (Figure 1B) and an equally marked decrease (~90%)
of RARγ mRNA levels (Figure 1C). Combining the con-
focal and mRNA evidence from the PPARγ and RARγ
data, it was clear that these cells underwent differenti-
ation to adipocyte as expected. We observed an approxi-
mate 20% decrease in IDE, 40% decrease in HHEX and a
greater than80% decrease in KIF11 mRNA levels when
comparing the adipocyte state with the pre-adipocyte state.
For the parallel protein level analyses, we used ubiqui-
tously expressed GTPase RAN as the loading control












































































Figure 1 Expression of the three genes within the 10q23 locus at both the pre-adipocyte and adipocyte stage of SGBS cell
differentiation. mRNA and protein were extracted from SGBS cells either at the pre-adipocyte or adipocyte stage cultured in differentiation
medium supplemented with Troglitazone for 27–49 days. Confocal image of SGBS cells in the pre-adipocyte and adipocyte states (49 days in
differentiation medium) are shown (A). In (B) change in real-time PCR normalized for 36B4 mRNA expression levels of the PPARG control before
and after differentiation; as expected, PPARG levels increase. In (C), change in real-time PCR normalized for 36B4 mRNA expression levels in HHEX,
IDE, and KIF11 mRNA expression levels; the levels of the RARG control decrease as expected. Western blots (D) were carried out to measure
either mRNA and protein levels of the genes of interest, respectively. Standard deviations were calculated based on four independent mRNA
replicates. A representative Western blot result is presented.
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converse to our mRNA observations, we observed a dra-
matic increase in HHEX protein levels (Figure 1D).
Time course expression analyses during SGBS
differentiation
We went on to examine the expression of HHEX, IDE
and KIF11 during the course of SGBS pre-adipocyte dif-
ferentiation to adipocytes. We carried out the time
courses in differentiation medium supplemented with a
PPARγ agonist, either being 2uM troglitazone or rosigli-
tazone. The results were highly comparable, with any
slight differences primarily due to potency differences of
the PPARγ agonist (Additional file 2: Figure S1).
Three independent differentiation assays were carried
out using rosiglitazone as the PPARγ agonist (Figure 2).
After adding the differentiation medium, we observed
increased lipid droplet accumulation over time as
expected (Figure 2A); in addition, we observed the
expected gradual increase of PPARγ mRNA (Figure 2B)
and protein (data not shown) expression. As seen in
Figure 2C, as early as 5 days after adding the differenti-
ation medium, along with the control RARγ we observed
a marked drop in the mRNA levels of HHEX, IDE and
KIF11; however, the expression patterns for the fourgenes differed over time, with HHEX, KIF11 and RARγ
mRNA levels remaining low after day 5, while the IDE
mRNA levels rebounded to some degree from day 13 to
day 23.
We also examined protein levels in the presence of
either troglitazone or rosiglitazone in the differentiation
medium, with PPARγ serving as a positive control and
36B4 serving as loading controls (Figure 2D and Add-
itional file 2: Figure S2). Again, in contrast to the HHEX
mRNA data, we observed a gradual increase of HHEX pro-
tein levels, starting as early as 5 days after adding the differ-
entiation medium and continuing to increase until day 23.
We observed a decrease of KIF11 protein levels from day 5
while protein levels for IDE largely remained steady over
time following a relatively modest drop after Day 5.
Expression during early adipogenesis of SGBS cells
As much of the expression differences occurred early on
in the time course experiments, we elected to explore
the mRNA and protein levels within 5 days of adding
differentiation medium. We observed an immediate drop
of HHEX mRNA expression, while we observed a rela-
tively more gradual drop of IDE, KIF11 and RARγ levels
and a gradual increase in PPARγ levels. In order to
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Figure 2 Expression time course of the three genes within the 10q23 locus during adipogenesis in SGBS cells. mRNA and protein
were extracted from SGBS cells at given time points (Days 0, 5, 9, 13, 16, 20 and 23) following introduction of the differentiation medium
supplemented with Rosiglitazone. Confocal images of the SGBS cells are presented at each of these time points (A). Real-time PCR normalized
for 36B4 mRNA expression (B, C) and Western blots (D) were carried out to measure either mRNA or protein levels of the gene of interest,
respectively. Standard deviations were calculated based on three independent mRNA replicates. A representative Western blot result is presented.
Zhao et al. BMC Medical Genetics 2012, 13:89 Page 4 of 5
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designed a second pair of primers targeting the 5’ end of
the gene (as opposed to the 3’ end for the first primer
pair) and found the data to be consistent (Additional file
2: Figure S3A and Additional file 2: Figure S4).
At the protein level, we explored HHEX and KIF11
expression in this short time period, as there was previ-
ous evidence they changed noticeably between Day 0
and Day 5 (Figure 2 and Additional file 2: Figure S2).
We observed an immediate increase in HHEX protein
levels while there was a relatively gradual decrease of
KIF11 protein levels within Day 1 and then dropped off
in Day 2 onwards (Additional file 2: Figure S3B).
Discussion
Our results point to all three genes within the 10q23
BMI and T2D associated locus having their expression
strongly influenced during adipogenesis. The most not-
able outcome from our experiments is with HHEX,
where mRNA levels drop dramatically early on in the
adipogenesis process while, conversely, there is a steady
increase in protein levels during the same period. In
addition, both mRNA and protein levels for the KIF11
gene product drop quickly after the start of adipogenesiswhile the protein levels for the IDE gene product remain
relatively stable during the same period, although the
mRNA levels drop quickly after the start of the process
followed by a rebound.
The known functions of these three genes have little
in common. KIF11 encodes a motor protein [18], IDE
encodes a protease [19] and HHEX encodes a transcrip-
tion factor. As such, their possible coordinated modes of
action would require further investigation.
The fact that we do not observe a direct correlation with
HHEX mRNA expression and protein levels may point to
protein stability differences between the pre-adipocyte and
adipocytes states, or conversely the mRNA may degrade
over time or perhaps, more specifically, just a subset of
the splice isoforms. Alternatively, the level by cell volume /
surface area could be less in adipocytes compared to pre-
adipocytes since adipocytes expand in cell volume during
adipogenesis. As such, further studies are warranted
through protein stability and cell-based assays to fully
understand the mechanisms of action in this regard.
Conclusions
Our data provide insights in to the possible mechanisms
of how all the genes at the T2D and pediatric BMI
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http://www.biomedcentral.com/1471-2350/13/89associated 10q23 locus could influence adipocyte differ-
entiation. Our conclusion is that all three genes are
important in this region for the expression of this trait
and we were unable to determine the ‘culprit’ gene as
there may well be not only one in this region. Further
studies are required to examine the possible mechanisms
of action suggested by our analyses.
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